Kontakis, Michael G.
Moulin, Marie
Andersson, Brittmarie
Norein, Norein
Samanta, Ayan
Stelzl, Christina
Engberg, Adam
Diez-Escudero, Anna
Kreuger, Johan
Hailer, Nils P.
Funding for this research was provided by:
Uppsala University
Article History
Received: 10 May 2024
Accepted: 1 February 2025
First Online: 11 March 2025
Declarations
:
: The cells used in the study were either cultures of the commercial human sarcoma cell line SaOS-2, or osteoblasts that were isolated from patients undergoing hip arthroplasty at Uppsala university hospital (UAS) in accordance with the Swedish Ethical Review Authority (approval number: 2020–04462).
: Not applicable.
: The authors declare no competing interests.